^
Association details:
Biomarker:TXN overexpression
Cancer:Cervical Cancer
Drug:cisplatin (DNA synthesis inhibitor)
Direction:Resistant
Evidence:
Evidence Level:
Resistant: C3 – Early Trials
New
Source:
Title:

Expression of thioredoxin 1 and peroxiredoxins in squamous cervical carcinoma and its predictive role in NACT

Excerpt:
...expression of thioredoxin 1, peroxiredoxin 1 and peroxiredoxin 2 protein was analyzed in 13 human cervical squamous cancer tissues...High expression levels of these proteins were related to a poor response to cisplatin-based neoadjuvant chemotherapy....
Secondary therapy:
Chemotherapy
DOI:
10.1186/s12885-019-6046-x